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Abstract 
Over 60 proteins have been detected in the tear film and among these lysozyme has attracted 
the greatest attention. Several techniques for elucidating the identity, quantity and 
conformation of lysozyme deposited on soft contact lenses have been developed. Lysozyme 
also deposits on the newly introduced silicone hydrogel (SH) lens materials, but in extremely 
low levels compared to conventional hydrogel lenses. Hence, a major analytical complication 
with the study of the SH contact lens materials relates to the minute quantity of deposited 
lysozyme.  
 
The first project of this thesis involved the development of a method whereby lysozyme mass 
extracted from SH lens materials would be preserved over time and would be compatible 
with an optimized Western blotting procedure. This methodological development was 
incorporated into a clinical study (CLENS-100® and Silicone Hydrogels – CLASH study) 
wherein the difference in the degree of total protein, the difference in lysozyme deposition 
and activity recovered from lotrafilcon A SH lens material when subjects used surfactant 
containing rewetting drops (CLENS-100®) versus control saline was investigated. The 
remaining experiments were in vitro experiments wherein the lenses were doped in artificial 
lysozyme solution containing 125I-labeled lysozyme. These experiments were performed to 
gain insight into the kinetics of lysozyme deposition on SH lens materials and also the 
efficacy of a reagent in extracting lysozyme from SH lens materials. 
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A protocol was developed whereby the percentage loss of lysozyme mass found on 
lotrafilcon A SH lenses was reduced from approximately 33% to <1% (p<0.001), following 
extraction and resuspension. The results from the CLASH study demonstrated that when 
subjects used a surfactant containing rewetting drop instead of a control saline drop total 
protein deposition (1.2±0.7 µg/lens versus 1.9±0.8 µg/lens, p<0.001), lysozyme deposition 
(0.7±0.5 µg/lens versus 1.1±0.7 µg/lens, p<0.001) and percentage lysozyme denaturation 
(76±10% versus 85±7%, p=0.002) were all reduced. The results from the kinetics study 
demonstrated that lysozyme accumulated rapidly on etafilcon A lenses (1 hr, 98±8 µg/lens), 
reached a maximum on the 7th day (1386±21 µg/lens) and then reached a plateau (p=NS). 
Lysozyme accumulation on FDA Group II and SH lenses continued to increase across all 
time periods, with no plateau being observed (p<0.001). The results from the extraction 
efficiency study showed that 0.2% trifluoroacetic acid/ acetonitrile was 98.3±1.1% and 
91.4±1.4% efficient in extracting lysozyme deposited on etafilcon A and galyfilcon lenses, 
while the lysozyme extraction efficiency was 66.3±5.3 % and 56.7±3.8% for lotrafilcon A 
and balafilcon lens materials (p<0.001).  
 
The results from these studies re-emphasize that novel SH lens materials are highly resistant 
to protein deposition and demonstrate high levels of biocompatibility.  
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1 Introduction 
The use of artificial materials (or “biomaterials”) within the body as replacement 
prostheses 1 has seen a rapid rise over the past fifteen years. As a consequence, the study 
of interactions between implantation materials and body tissues has become increasingly 
important. Once inserted, the “biomaterial” undergoes various interactions with the host 
biological environment and the “biocompatibility” of the given material depends upon 
many factors, related to both the host and implanted material. To date, the biomaterial to 
receive the greatest clinical exposure is the soft contact lens.  
 
Contact lenses suffer from the same problems of deposition that other biomaterials 
exhibit, being rapidly coated with a variety of proteins, lipids and mucins. 2-9 The first 
event observed at the interface between a contact lens and tear fluid is protein 
adsorption.10, 11 Of late, the study of interaction of tear proteins with contact lenses has 
become an important field of research, following the widespread use of contact lenses in 
many physiological and pathological conditions. Tears have a rich and complex 
composition, allowing a wide range of interactions and competitive processes. Protein 
adsorption on contact lenses is the overall result of various types of interactions between 
the different components present, i.e. the chemical composition and the surface charge, 
the structure of the protein molecules, the nature of the medium (tears) and many other 
solutes present in tears. 
 
Several techniques for elucidating the identity, quantity and conformation of deposits on 
soft contact lenses have been developed. Using these methods, many studies have 
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demonstrated that lysozyme is the principal soilant on the lens surface. Lysozyme also 
deposits on the newly introduced silicone hydrogel (SH) lens materials, but in extremely 
low levels compared to conventional hydrogel lenses. 12-14 Hence, a major analytical 
complication with the study of the SH contact lens materials relates to the minute 
quantity of deposited lysozyme.  
 
This thesis is partially focused on optimization of existing analytical techniques, such that 
the lysozyme deposits extracted from SH contact lenses can be accurately and sensitively 
analyzed. This project will also involve the use of 125I labeled-lysozyme to gain insight 
into the kinetics of lysozyme deposition on SH lens materials and also the efficacy of a 
reagent in extracting lysozyme from SH lens materials. Finally, this thesis will also 
investigate the impact on protein deposition by treating SH lenses with a novel rewetting 
agent, following collection of lenses from carefully controlled clinical studies. 
 
With a greater understanding of protein deposition on contact lens materials, further 
enhancements in contact lens materials can be made. This will aid practitioners in 




2 Literature Review 
2.1 Contact lenses 
Contact lenses are one of the most widely used biomedical devices in the world. 9 They 
have been studied extensively with respect to their level of deposition, primarily due to 
their non-invasive use and easy recovery compared to other biomaterials in contact with 
biological fluids. 1 Contact lens materials can broadly be classified into two types, (a) 
water-containing soft (hydrogel) and (b) non-water containing rigid gas-permeable (RGP) 
materials.  
 
2.1.1 Conventional contact lens materials 
Hydrogels are water-absorbing, hydrophilic polymeric materials. The amount of water 
adsorbed by the hydrogel is described by the term “equilibrium water content” (EWC) 
and this factor strongly influences the polymer’s surface, mechanical and transport 
properties. 15 The first successful material of this type (poly-2-hydroxyethyl methacrylate 
[polyHEMA]) was developed by Wichterle and Lim in the late 1960’s as a general 
purpose surgical material. 15 Over 90% of contact lens wearers use hydrogel lenses, due 
to their increased initial comfort and reduced sensation of dryness. 16  
 
The corneal metabolic requirements of patients vary with each individual 17 and some 
patients with higher prescriptions, may exhibit corneal edema and develop chronic 
hypoxic complications if fitted with low water content materials, due to the increased 
thickness of the lenses. 18, 19 These patients require high water content hydrogels to 
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reduce such complications. Two principal strategies are available to increase the water 
content of hydrogels above that of polyHEMA. Small quantities of charged groups such 
as methacrylic acid or larger amounts of hydrophilic, neutral groups such as polyvinyl 
alcohol or N-vinyl pyrrolidone are added to polyHEMA or methyl methacrylate to raise 
their equilibrium water contents to 60% or greater.     
 
Commercially available contact lens materials can be divided into various groups 
depending on their charge and water content. The FDA currently classifies contact lens 
materials into four groups, depending upon their charge and water content (Table 2.1). 
 
Table 2.1 FDA classification of hydrogel contact lens materials 
FDA Classification Group I Group II Group III Group IV 
Water Content Low High Low High 
Charge Non-Ionic Non-Ionic Ionic Ionic 
Low = < 50% water; High = > 50% water; Ionic = Charged; Non-Ionic = No charge  
 
There are several different wearing modalities utilized for hydrogel lenses. They are as 
follows: 
1. Daily wear (DW) lenses are cleaned and removed each night and are discarded 
after a period of time. This period varies from one day to one year, but usually 
after 30 days or less. 
2. Extended wear (EW) contact lenses are worn for 7 days and 6 nights, with the 
lens disposal occurring after this time-frame. 
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3. Continuous wear (CW) modality is a relatively new modality, which requires 
little, if any, lens maintenance. Under this modality, contact lenses remain on the 
ocular surface for up to 30 days and nights without removal, after which they are 
discarded. 
 
In order to prevent corneal infection, the corneal tissues require sufficient oxygen to 
function without compromising cellular processes. Clearly, this is more difficult under 
closed-eye conditions, when the lid severely limits oxygen transport to the cornea. In 
order to provide a healthy ocular surface under EW and CW conditions it is important 
that the lens material provides a substantial amount of oxygen to the ocular surface. This 
has been achieved through the recent development of novel silicone hydrogel contact lens 
materials. 
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2.1.2 Silicone hydrogel contact lens materials 
Preliminary attempts (in the 1970’s and early 1980’s) to use silicone within hydrogel 
lenses in the silicone elastomers failed due to the exposure of hydrophobic silicone on the 
surface of the lens material. This resulted in increased lens binding to the cornea, 
enhanced lipid deposition and decreased in-eye wettability of the lens. 20 In order to cope 
with this problem a surface modification process was required, which would increase the 
hydrophilicity of the lens surface and make the surface more wettable and hence more 
biocompatible. 21 Additionally, the surface treatment should maintain a stable tear film 
layer, be non-irritating, provide low bacterial adherence and minimize deposition of 
substances from tears. 22  
 
Consequently, these silicone hydrogel (SH) lenses were developed and were first 
introduced into the market in 1999. 23 The addition of silicone to the lens increases the 
material’s oxygen transmission, while the hydrogel component allows for fluid transport 
and lens movement. The combination of these two components allows for safe, extended 
wear of lenses when compared to conventional lens materials. 20, 24 These lens materials 
transmit 5-6 times more oxygen than the conventional polyHEMA-based lenses and 
hence could provide safe overnight wear for up to 30 continuous nights. 24  
 
Currently four silicone hydrogel lenses are available in the North American market. 
Table 2.2 summarizes the differences between the four SH materials.  
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Table 2.2 Characteristics of currently available silicone hydrogel lenses 
Proprietary name 
 Focus® Night 









Water content (%) 24 36 47 33 
Oxygen 
Permeability (Dk) 
140 99 60 110 
Centre thickness 
(mm) -3.00D 
0.08 0.09 0.07 0.08 
Oxygen 
Transmissibility 
(Dk/t) at 35˚C 
175 110 86 138 
FDA group I III I I 
USAN Lotrafilcon A Balafilcon A Galyfilcon A Lotrafilcon B
Stiffness (g/mm2) 130 110 55 100 
Base Curve (mm) 8.4, 8.6 8.6 8.3, 8.7 8.6 
Total Diameter 
(mm) 
13.8 14 14 14.2 
Year of introduction 1999 1999 2003 2004 
 
The oxygen permeability of a material is referred to as the Dk. The units of 10 -11 cm2/s 
ml O2/ml X mm Hg are often omitted for convenience. Dk value is a physical property of 
a contact lens material and describes its intrinsic ability to transport oxygen. “D” is the 
diffusion coefficient – a measure of how fast dissolved molecules of oxygen move within 
the material and “k” is a constant representing the solubility coefficient or the number of 
oxygen molecules dissolved in the material. 
  
Oxygen transmissibility is referred to as Dk/t, with units of 10 -9 cm/s ml O2/ml X mm 






The surfaces of the lotrafilcon (A and B) lenses are permanently modified in a gas plasma 
reactive chamber to create an ultrathin (25 nm), high refractive index, continuous 
hydrophilic surface. 23, 25 Balafilcon lenses are surface treated in a gas plasma reactive 
chamber, which transforms the silicone components on the surface of the lenses into 
hydrophilic silicate compounds. 23, 26 This results in glassy, discontinuous silicate islands 
and the hydrophilicity of these areas bridges over the underlying hydrophobic balafilcon 
material. Galyfilcon lenses incorporate a long chain, high molecular weight molecule 
called Hydraclear™, which maintains flexibility and moisture. This wetting agent is 
present throughout the lens and hence no surface treatment is required for these lenses. 27  
 
With the introduction of these novel SH lens materials, hypoxia and oedema related 
problems have been solved; however, as will be discussed in the following sections, the 
problems such as tear related deposition and wettability still remain unsolved. 
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2.2 Contact lens deposits 
One of the major problems with hydrophilic contact lenses is that they are susceptible to 
spoilage from constituents of the tear film, which include a wide variety of proteins, 
lipids and mucins. 2-9 At extreme levels of build-up, these deposits are associated with 
diminished visual acuity 28 and a feeling of dryness and discomfort. 29 Deposits can 
ultimately lead to more serious clinical conditions such as hypersensitivity reactions and 
giant papillary conjunctivitis. 30-33 Moreover, these deposits potentially increase the risk 
of bacterial attachment by providing a solid substrate and shelter. 34-36  
 
The adsorption of tear derived substances at the contact lens interface is highly complex 
and dependent upon a number of factors. Notable amongst these are the material’s 
equilibrium water content (EWC), 3 surface charge, 37 protein size/ charge 38 and age of 
the lens material. 29 However, the relative importance of the different components of 
deposited films to these clinical effects remains largely unknown.  
 
As already mentioned, the newly introduced SH contact lenses have significantly 
increased oxygen transmission due to the incorporation of siloxane groups. 14, 39, 40 The 
incorporation of silicone results in an increased degree of hydrophobicity, which results 
in increased lipid deposition compared with other non silicone-containing materials. 24 
However, these lens materials do deposit extremely low levels of protein compared to 
conventional hydrogel lenses, with typical levels being in the < 20 µg/lens range. 12-14 
Among the conventional lens materials, Group I lenses typically attract less than 10 µg of 
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protein, Groups II and III lenses approximately 30 µg, and Group IV lenses 1000 µg or 
more. 2, 3, 5, 7, 37, 41-49 
 
2.2.1 Protein deposits on contact lenses 
Proteins primarily are deposited onto the contact lenses from the tear fluid. Table 2.3 lists 
the average concentration of some important tear proteins. Proteins deposit on the contact 
lenses as films and these protein films are invisible during the early stages of the 
spoilation process, but with the advancement of time, the protein denatures and they 
assume a thin, translucent, whitish appearance. 50 These protein deposits remain primarily 
on the surface, but in high water content lenses they may penetrate into the lens matrix. 51 
All proteins in the tear film have the potential to form contact lens deposits, although, 
several factors ultimately influence the type, quantity and structure of such deposits.  
 
 
Figure 2.1 Protein deposits on contact lens. 
(Picture courtesy of Dr. Lyndon Jones) 
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Total Protein 751 
Lysozyme 236 
Lactoferrin 184 
Tear specific pre-albumin 123 
Albumin 130 







Protein deposition onto hydrogel lens materials is a highly complex process, depending 
upon the charge and size of the protein, environmental pH, charge and water content of 
the substrate and competition between the various tear film constituents that are present. 
2, 41, 53 Protein has been the major focus of both identification and quantitation studies of 
contact lens deposits. Estimates of the total amounts vary but fall within a reasonably 
well-defined range. Group I lenses typically attract less than 10 µg of protein, Groups II 
and III lenses approximately 30 µg, and Group IV lenses 1000 µg or more. 2, 3, 5, 7, 37, 41-49  
Silicone hydrogel lens materials deposit extremely low levels of lysozyme compared to 
conventional hydrogel lenses, with typical levels being in the < 20 µg/lens range. 12-14 
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Tear film proteins frequently detected on hydrogel contact lenses include lysozyme, 
lactoferrin and albumin, 45, 50, 53 and among these lysozyme has been the most widely 




Lysozyme (also called Muramidase) is a bacteriolytic enzyme that was discovered by 
Fleming in 1922. 56 It is found in mammalian urine, saliva, tears, milk, cervical mucus, 
leukocytes and kidneys. 52 Tear lysozyme is derived from the acinar and ductal epithelial 
cells of both main and accessory lacrimal glands. 57, 58  
 
2.3.1 Lysozyme structure 
Lysozyme is a compact globular protein molecule with a molar mass of 14,500 D. 58 It 
has a slightly ellipsoidal shape, and its dimensions are 45 X 30 X 30 Å. It is a compact 
protein of 129 amino acids which folds into a compact globular structure. 59 The 129 
amino acid sub-units are cross-linked by four disulphide bridges. 60 There is a close 
cluster of basic groups (Arginine 45 and 68 in one region, Arginine 61 and 73 in a second 
and Arginine 5, 125 and 128 in a third) which form the highly positively charged surface 
regions of lysozyme, which give it a very high isoelectric point of 11.1. The polypeptide 
chain forms five helical segments, a 3 stranded anti-parallel Beta sheet that comprises one 
wall of the binding cleft.  A deep cleft contains the active site (described later in Section 
2.3.1.3) which divides the molecule into two domains. These domains are linked by 
alpha-helix residues.  One domain consists of residues that have Beta Sheet structure; the 
other domain has in its residues that are helical in nature. 59   
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2.3.1.1 Structural aspects of lysozyme – from the viewpoint of an antibody 
Lysozyme, in its native globular state contains two fragments which have immunologic 
activity and encompass two independent antigenic determinants. 61 One of these 
immunologically active fragments consists of two peptides, derived from the NH2-
terminus and the COOH-terminus of lysozyme linked together by a disulphide bond. The 
second immunologically active component isolated was a large fragment derived from 
the region located between residues Leucine 57 and Arginine 107 of the lysozyme 
sequence. 61 This peptide which contains two disulphide bridges, is also capable of 
binding to anti-lysozyme antibodies. Similar structure was obtained for lysozyme in 
further experiments conducted using epitope mapping. 62, 63  The location of these regions 
in the three-dimensional structure of lysozyme in shown in Figure 2.2. 
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Figure 2.2 Schematic drawing of the main chain conformation of lysozyme. 59 
 
2.3.1.2  Structural comparison of human lysozyme versus hen egg lysozyme 
X-Ray crystallographic studies 60, 64 and far-UV circular dichroism studies 65, 66 suggest 
that the two enzymes namely, human lysozyme and hen egg lysozyme have very similar 
secondary structures. Even though the sequences in these two lysozymes are different, 67 
sizable numbers of substitutions are non-conservative; hence the structures and functions 
are highly similar. 59 Moreover, if the ionic strength was maintained constant within a 
certain range (pH 5 to 9), the activity of both these enzymes were found to be same. 59, 68   
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2.3.1.3 Structure – Activity Relationship (SAR) 
Lysozyme is instrumental in destroying certain species of bacteria which are gram-
positive. These gram-positive bacteria possess an outer coat of a peptideglycan (sugar) 
polymer (or peptidoglycan), which, in gram-negative bacteria, is only transiently stained 
since those bacteria are covered by a second, outer lipid membrane. 69  
 
Lysozyme hydrolyzes or breaks up the glycan (sugar polymer) components of the 
peptidoglycan of gram-positive bacteria. Specifically, lysozyme breaks β-1,4 glycosidic 
bond of the oxygen bridge between the repeating glycan units of N-acetylmuramic acid 
(NAM) and N-acetylglucosamine (NAG), which is responsible for its anti-bacterial 
properties.   
 
 
Figure 2.3 Cut-away diagram of a gram-positive bacterium. 69 
The gram-positive bacterium has two boundary layers: a bilipid layer (membrane) and a peptidoglycan 
layer (outer coat).  
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A portion of the bacterial peptidoglycan is able to fit in a groove on the outer surface of 
the enzyme that contains the active site (Figure 2.4). The active site contains two amino 
acid components (Glutamine and Aspartic Acid) whose carboxylate groups participate in 
the hydrolysis. 59 The molecular mechanism of lysozyme catalysis at the active site 
involves multiple steps, in which a proton is donated by an uncharged Glutamine residue 
at the active site by breaking the glycosidic bond. 69 At completion, the original forms of 
the enzymes are regenerated and the hydrolyzed chains of the peptidoglycan leave the 
active site of the enzyme. 
 
 
Figure 2.4 Outline diagram of a lysozyme molecule. 69 
The enzyme is a globular polypeptide that has a groove (darker area near the top of the enzyme) into which 




2.3.2 Lysozyme and contact lenses 
The major proteins that are deposited on contact lenses include lysozyme, lactoferrin and 
albumin, 45, 50, 53 and among these lysozyme has been the most widely studied. 2, 7, 38, 54, 55 
Karageozian first reported that the principal component of deposits that presented 
problems with contact lens wear was lysozyme, which may be selectively adsorbed and 
denatured on the lens surface. 70 Many others have since confirmed the predominance of 
lysozyme in lens deposition. 7, 42, 44-46, 71, 72   
 
Lysozyme is a major component in tears and of contact lens deposits. It accounts for 
approximately 40% of total protein found in tears and is the major protein (approximately 
36 to 95% depending on lens type) deposited on hydrogel contact lenses. 73, 74 In addition 
to its bactericidal properties (described earlier), lysozyme is also reported to have anti-
inflammatory properties in the tear film, although the mechanism through which this 
action occurs is unknown. 75 Exploration of lysozyme deposition (quantity and 
conformation) on a number of different traditional and silicone hydrogel surfaces is of 
growing interest due to observations that patients using silicone hydrogel lenses are prone 
to develop papillary conjunctivitis, 76-78 possibly due to the denaturation of lysozyme on 
the lens materials.  
 
Lysozyme is a positively charged molecule and this, coupled with its small size, results in 
its increased adsorption onto negatively charged substrates such as FDA group IV contact 
lens materials. 3, 7, 38, 55, 79 However, silicone hydrogel lens materials deposit extremely 
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low levels of lysozyme compared to conventional hydrogel lenses, with typical levels 
being in the < 20 µg/lens range. 12-14 
 
In order to measure the low levels of lysozyme deposited on SH lens materials an 
accurate method to quantify protein levels in nanogram quantities is required. The 
following section discusses the options available to quantify such low levels of protein. 
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2.4 Methods to quantify proteins deposited on contact lenses 
Several microscopic, photometric and imaging techniques have been used to investigate 
protein deposits on contact lenses. 5, 41, 44, 80, 81 The major limitation of microscopic and 
imaging techniques is that they are generally not suitable for accurate quantitation 
purposes. 9 Various biochemical assays including Enzyme-Linked Immunosorbent Assay 
(ELISA), High Performance Liquid Chromatography (HPLC) and Sodium Dodecyl 
Sulphate Polyacrylamide Gel Electrophoresis (SDS-PAGE) are useful because of their 
increased sensitivity, accuracy and ability to target specific proteins.   
 
2.4.1 Enzyme-linked immunosorbent assay (ELISA) 
Enzyme-linked immunosorbent assay (ELISA) is a widely used method for investigation 
of tear film proteins. ELISA utilizes antibodies bound to solid surfaces, such as plastic or 
polystyrene micro-titre plates to quantify protein of interest. 82 ELISA relies on antibody 
recognition of the protein of interest in solution. A colorimetric, fluorescent or 
chemiluminescent reaction is used to quantify the amount of protein bound to the well, 
followed by detection of the specific signal. 82 
 
The major advantage of ELISA is the ability to process high number of samples (up to 
96) at the same time and this method also reduces the need for handling the sample. The 
disadvantage with this method is that it can cross-react with non-targeted proteins, or the 
interaction between antibody and target can be disrupted by other sample components. 83   
  20
2.4.2 High Performance Liquid Chromatography (HPLC) 
HPLC separates proteins based on molecular size in a column support through a tightly 
packed matrix (such as glass, plastic or silica beads) under high pressure. There are 
several types of HPLC and Size Exclusion HPLC is the widely used method for 
quantifying individual proteins in solution. The major advantage of HPLC is that several 
proteins can be quantified from a single experiment. However, Fullard (1988) found an 
unusually high absorbance for lysozyme, which may decrease the accuracy of the assay 
and could lead to erroneous conclusions. 84 
 
2.4.3 Sodium dodecyl sulphate - Polyacrylamide gel electrophoresis followed 
by Immuno blotting 
Sodium dodecyl sulphate - Polyacrylamide gel electrophoresis (SDS-PAGE) is a specific 
type of gel electrophoresis that uses sodium dodecyl sulphate (SDS) as a detergent to 
confer a negative charge to a protein and polyacrylamide as a matrix to separate proteins 
according to size. Electrophoresis refers to the migration of charged molecules in solution 
in response to an electric field. Electrophoresis is simple, rapid and highly sensitive and 
can be used to study the properties of a single charged species, and as a separation 
technique. 85 Once physically separated, proteins are visualized using antibodies and 
chromogenic, fluorescent or chemiluminescence is used to quantify the binding of the 
antibodies to the protein. Resolution of proteins that migrate together in the gel is 
accomplished by the specificity of the antibody; a single antibody will recognize a small 
portion of the protein of interest, thereby reducing the potential of visualizing co-
migrating tear film components. In addition immunological visualization allows 
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identification of variations in protein conformation, such as unexpected polymerization or 
interaction with other proteins. 86, 87 
 
2.4.3.1 PhastSystem™   
The PhastSystem™ (Amersham Pharmacia Biotech, Baie d’Urfe, QC, Canada) is an 
automated mini-gel system that combines both electrophoresis and immunoblotting into a 
single apparatus. This system is different from that of traditional larger gel 
electrophoresis systems, in that it utilizes pre-cast, extremely small (4.5 cm X 5 cm) SDS 
gels for protein separation. These extremely small SDS gels confer increased sensitivity 
with a minute sample volume requirement, compared to other electrophoresis and 
immunoblotting systems. (Figure 2.5)  
 
 
Figure 2.5 The Phast System™ 
 
Unlike other gel electrophoresis systems, the protein-containing loading buffer, in 
volumes from 0.3 µl to 1 µl, is applied to well combs with up to 12 lanes rather than 
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directly into wells cut into a gel. These disposable well combs are then automatically 
applied to the mini-gel for electrophoretic separation. The temperatures, voltage, current 
and power are automatically regulated throughout the separation process. Western 
blotting is similarly automated and simplified by the PhastSystem™. The small size of 
the gels and the small sample volume applied to the gel make the PhastSystem™ unique 
among all other systems. The low sample volumes and small pre-cast gels also provide an 
added level of sensitivity and flexibility, especially for proteins in low concentrations. 88, 
89 Several researchers have used the PhastSystem™ to detect extremely low 
concentrations of tear film proteins. 88-90 
 
Whilst the methods such as HPLC or ELISA can provide other advantages such as 
enhanced efficiency in quantifying several proteins at the same time (HPLC) or provide 
greater sample throughput (ELISA), electrophoretic separation followed by 
immunoblotting using the PhastSystem™, provides us with the best tool for quantifying 
individual proteins in extremely low concentrations, while at the same time allowing 
visualization of the protein to assess cross-reactivity between the antibody and protein of 
interest and possible aggregation or polymerization of the protein. Using this technique, a 
method has been optimized to quantify lysozyme deposition on SH lenses. 13 
 
The following section discusses the possible difficulties associated with the analysis of 
lysozyme deposited on SH lenses through this optimized procedure, which primarily 
arises due to its deposition in low quantities.  
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2.5 Difficulties associated with contact lens deposit analysis 
2.5.1 Lysozyme and its stability in contact lens deposit analysis 
Lysozyme is a relatively stable protein when compared to most other proteins. 7 The 
properties of lysozyme do not change at pHs between 1 and 8. 91 A study by Ikeda and 
colleagues (1967) showed that lysozyme denatures only when the pH is above 12. 92 The 
thermal stability of lysozyme in various solutions was studied by Hamaguchi and Sakai 
(1965) and they found that its structure is not affected by heat up to 55˚ C. 93 Moreover, 
by increasing the temperature only the internal fold of lysozyme is disrupted and no 
changes occur in the helical part at high concentrations of organic solvents.  
 
Despite its stability, lysozyme might undergo changes in its conformation during the 
process of contact lens deposit analysis. In the optimized procedure developed in our lab, 
the various steps involved include extraction of deposits using an extraction buffer, 
lyophilization, storage and resuspension. 13 Any of these steps could potentially alter the 
native conformational state of lysozyme and could result in failure to be recognized by 
the antibody.  
 
To-date, no study has been conducted on the effect of storage on lysozyme deposits that 
have been extracted from contact lens materials. In two recent studies undertaken on tear 
and salivary samples, it was demonstrated that a reduction in lysozyme quantity occurs as 
a function of storage time. 94, 95 Preliminary results in our laboratory have demonstrated 
that lysozyme deposits extracted from SH contact lens materials also demonstrate a loss 
in total mass after lyophilization and resuspension, as a function of storage time when 
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assessed by Western blotting. These data (unpublished) indicate that this loss in mass is 
particularly problematic with lysozyme deposition on lotrafilcon A lens materials. This 
loss represents a potential source of error when quantifying total lysozyme deposition. 
Moreover, the amount of lysozyme extracted from SH materials is very low, such that 
even a minimal loss would be significant in the interpretation of the total amount of 
lysozyme deposited. Hence there is a need to devise a method whereby lysozyme mass 
extracted from SH lens materials would be preserved over time and would be compatible 
with the optimized Western blotting procedure. 13 
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2.5.2 Elution of proteins from contact lens materials 
To-date, elution of proteins from the material remains the best option to quantify specific 
proteins deposited onto contact lenses. 6, 41, 42, 96 The accurate quantification of a protein 
deposited on a surface requires that all or at least a known percentage of the protein of 
interest be removed. Hence the ability of an extraction buffer to extract the proteins for 
analysis is a focus of major interest.  
 
The most common method for protein extraction involves the use of a combination of 
detergents and reducing agents to break chemical bonds between the adsorbed proteins 
and the contact lens surface. Some of the agents that have been incorporated in elution 
mixtures include sodium dodecyl sulphate (SDS), dithiothreitol (DTT), urea, NaOH, 
ethylene diamine tetraacetic acid (EDTA) and Tris-HCL. 5, 7, 29, 41, 42, 45, 46, 53, 97-101  
 
2.5.2.1 Review of various extraction procedures in the literature 
One of the significant earlier works on deposit removal was conducted by Wedler in 
1977. 45 He considered the removal of deposits on contact lenses by various chemical 
reagents including urea, guanidine hydrochloride, potassium thiocyanate, potassium 
perchlorate, hydroxylamine, EDTA, SDS and DTT. However, he found that the deposits 




Many other researchers have used these techniques since then, particularly SDS. 5, 29, 41, 42, 
46, 53, 97-99 SDS, a stong detergent and DTT, which cleaves the disulphide bonds between 
and within the proteins, are required to break apart chemical bonds and solubilize 
proteins for quantification. Urea, a hydrogen bond cleaving agent, is used for the 
denaturation of proteins and as a mild solubilization agent for insoluble or denatured 
proteins. EDTA is a chelating agent that binds metal ions; however some studies 
demonstrate that EDTA is not effective in extracting protein deposits. 45 Tris-HCL is a 
buffering agent that maintains the pH of the extraction solution. In addition to chemical 
“mixtures” to extract proteins, heat and sonication have been utilized to increase the 
efficiency of protein extraction, theoretically by agitating the biomaterial in the extraction 
solution and helping to break apart the bonds. 102, 103 However, it became apparent from 
the study by Yan and co-workers (1993) that these common extraction procedures may 
fail to remove even 75% of the total material on lenses. 46 
 
Keith and co-workers (1997) developed a quick, simple and efficient extraction 
technique. 74 They used an extraction solvent consisting of 50:50 mix of 0.2% 
trifluoroacetic acid and acetonitrile. Extraction efficiency for lysozyme from laboratory 
deposited group IV lenses was found to be approximately 100%. A similar extraction 
procedure has been adopted by many other researchers since then. 12, 104 However, the 




2.5.3 Radiotracer technique to determine extraction efficiency  
For studies where proteins are eluted from lenses it is vital to ensure that the protein 
extraction method is effective. Some researchers have utilized the UV spectrophotometer 
to assess protein extraction efficiency. 13, 105 Using this technique, it is possible to 
determine the extraction efficiencies of lenses with no UV blocking properties such as 
etafilcon A. However, it is not possible to use this method on SH lenses as, unlike 
etafilcon A lenses (Group IV), SH lenses deposit extremely low levels of lysozyme, 
making UV spectrophotometry too insensitive.  
 
Hence, a more sensitive method to estimate the efficiency of lysozyme removal from SH 
lenses has to be employed. One of the positive avenues is the use of radioactively labeled 
lysozyme. The isotope 125I has been used to radioactively label lysozyme and other 
proteins in previous studies. 2, 48, 103, 106, 107 The isotope is incorporated into the protein 
and radioactivity can be used to assess the level of protein binding. Thus, I sought to 
quantify the percentage of lysozyme extracted by 0.2% trifluoroacetic acid/ acetonitrile 




2.6 Kinetics of lysozyme deposition  
Following insertion onto the eye, hydrogel contact lenses rapidly adsorb components 
from the tear film, particularly protein, 2, 3, 7, 37, 47, 48 lipid, 5, 29, 79, 96, 108 and mucin. 8  A 
number of studies have investigated the kinetics of protein or lipid deposition on contact 
lens materials in vitro, 8, 38, 48, 54, 109-113 and in vivo 41, 42, 44, 79, 98, 104, 114, 115 on conventional 
hydrogel lens materials. However, to-date no study has investigated the kinetics of 
protein or lipid deposition on SH lens materials.  
 
Since deposition is a time-dependent process, empirically derived values will be highly 
dependent upon the age of lenses tested. Previous studies show that lenses recovered 
within the first few minutes of wear demonstrate coatings of some degree and the process 
of deposition continues over time. 41, 42, 116, 117 Sack and co-workers (1996) found that 
lysozyme gets deposited on Group IV lenses at a constant rate of 2.2 µg/ minute during 
the initial part of open-eye wear; this later leveled to a steady state. 98 Lin and co-workers 
(1991) showed that accumulation of components is not consistent, with some entities 
showing faster binding rates. 42 Keith and co-workers (2003) have accurately plotted the 
medium term build-up of lysozyme on Group IV lenses. 104 They found a mean 
concentration of 55 µg/ lens after 15 minutes of wear, which reached a maximum at 
around 1300 µg/ lens after six days of wear and also that the time to reach plateauing 
varied from day four to eleven between subjects. 104 Consistent with this study, Jones and 
co-workers (2000) determined that surface deposition on Group IV lenses plateaued on 
day one, with intramatrix deposition continuing to increase up to seven days. 118 Surface 
protein on Group II lenses also peaked within one day, but total protein accumulation 
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continued for up to 30 days. 118   The concept of plateauing is also supported by Richards 
(1992) and Tripathi (1992). 44, 119 In comparing the deposition on Group II lenses, Jones 
and co-workers (1996) found an increase in lipid by 80% and of protein by 152% at three 
months compared with one month of wear. 29 Gellatly and co-workers (1988) noted that 
only 3% of patients whose lenses had been worn for an estimated total of 2600 hours or 
less showed a significant visible deposition, whereas 80% of patients whose lenses were 
older than 2600 hours showed this degree of deposition. 28 Maissa and co-workers (1998) 
observed more surface proteins on ionic materials after three months compared with one 
month of wear, but no change over this time for non-ionic materials. 79 Jones and co-
workers (2000) observed that lipid accumulation ceased by the end of day one on Group 
IV lenses but continued unabated for at least four weeks for Group II lenses. 118 Lin and 
co-workers (1991) observed that lysozyme accumulation as measured by SDS-PAGE, 
increased with wearing times up to one week on Acuvue® lenses (Group IV), but after 24 
hours wear lysozyme accumulation did not increase on the SeeQuence lens (Group I). 42 
 
It is widely recognized that the adsorption of proteins at the contact lens surface is 
complex and depends upon a number of factors. Notable among these are material water 
content and surface charge. 3, 7, 37, 42, 46, 47, 79, 96, 120 Knowing the rate of protein deposit 
accumulation and at what point in lens wearing time the accumulation reaches either a 
maximum or a plateau level could be clinically relevant to patient symptoms and be 
helpful in designing clinical investigations of hydrogel lenses and associated lens care 
products. As the most abundant tear protein, lysozyme approximates 90% of the protein 
found on group IV contact lens and is therefore often used as the prototypical marker for 
  30
protein accumulation. 7, 74, 98  Although, the quantity and conformation of lysozyme 
deposited on SH lens materials have been reported, 12-14 no study has looked at the 
deposition of lysozyme as a function of time in SH lens materials. 
 
2.6.1 Advantages of in vitro experiments and radiotracer technique 
Soft lenses are not always obtained for analysis from clinical sources. A number of 
studies have found artificial tear solutions an attractive option in determining the binding 
affinity of different components and the mechanisms involved in such binding. 110, 121-129 
The principal advantages are that many experimental variables are eliminated, 
quantitation can be enhanced by labeling the species fluorometrically or radiometrically, 
and simple hypotheses can be tested without having to engage in a resource consuming 
clinical trial. 
 
A number of quantitative protein methods have been applied to the analysis of protein 
deposits on contact lenses. However, many of these techniques require complex 
extraction procedures which may not be 100% efficient. The radiochemical assay is:  
1. Quantitative and reproducible with a low detection limit. 
2. Able to assess a large number of samples. 
3. Compatible with all contact lens materials. 
4. Not dependent on complex extraction techniques. 
5. Able to detect surface as well as bulk protein. 
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Hence in this thesis, I wanted to gain insight into the kinetics of lysozyme deposition 
on SH lenses and compare it with Group II and Group IV conventional hydrogel lens 





2.7 Influence of rewetting drops on protein and lysozyme deposition  
In addition to oxygen transmission, adequate contact lens wettability is critical to 
achieving long-term physiological compatibility and successful, problem-free contact 
lens wear. 130 With conventional lens materials, wettability reduces over the wearing 
period and replacing a lens frequently results in the maintenance of a more wettable, 
“cleaner” surface. 29, 131, 132 When it comes to in-eye wettability, SH lenses are inherently 
hydrophobic and hence, as already discussed, require a surface modification process to 
provide a hydrophilic, wettable surface. 23, 25 Of additional concern is the fact that SH 
materials deposit greater quantities of lipid than conventional materials, 12 which may act 
to negate the impact of the surface treatment and result in a hydrophobic surface. To-date, 
no work has been published that examines the wettability of SH lenses in eye. 
 
One of the means of modifying the lens surface to enhance wettability is to treat the lens 
with a wetting agent such as a surfactant. Surfactant-containing contact lens care systems 
are extensively used within the contact lens care industry for cleaning purposes. 
However, because of the ability of surfactants to associate at interfaces, it can be 
expected that surfactants will also adsorb onto the surface of hydrogels and thus 
potentially influence the surface wetting characteristics. These effects may have 
significant implications in terms of perceived patient comfort on both initial insertion and 
at the end of the wearing period. Surface modification by the addition of surfactants, 
which has until now been neglected, may be more important to the patient than any 
cleaning action. To date, only one study has examined this effect, 133 and this provided 
confirmation that surfactants can positively influence initial lens comfort.  
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An appreciation of the physicochemical basis behind lens wettability may enable targeted 
development of solutions, whose sole function is to produce enhanced lens comfort 
through in-eye surface modification of materials. Hence it is important to investigate the 
impact of treating SH lenses during their wearing period with a novel rewetting agent that 
has been specifically developed to reduce in-eye deposition. Hence, this thesis will also 
investigate the effect of a surfactant containing rewetting drop on protein deposition on 





3 Thesis Objectives 
This thesis will involve the analysis of contact lenses following their collection from 
carefully controlled clinical trials and also by artificially soiling lenses to fulfill four 
objectives: 
 
1. To devise a method whereby lysozyme mass would be preserved over time and 
would be compatible with the optimized Western blotting procedure. 
2. To determine the efficiency of 0.2% trifluoroacetic acid/ acetonitrile in extracting 
lysozyme from SH and Group IV contact lens materials by artificially doping 
lenses with 125I labeled lysozyme. 
3. To determine lysozyme deposition as a function of time in Group IV, Group II 
and SH contact lens materials by artificially doping lenses with 125I labeled 
lysozyme.  
4. To determine the difference in the degree of total protein, the difference in 
lysozyme deposition and activity recovered from lotrafilcon A SH lens material 
when subjects used a surfactant containing rewetting drop (CLENS-100®) versus 
a saline control, following its removal from a carefully controlled clinical study.  
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4 Materials and Methods 
4.1 Stabilization study 
The sample variables examined in this study included: (1) the presence or absence of gel 
loading buffer (GLB); (2) temperature (-20°C and -70°C); (3) composition of two 
reconstitution buffers (RB and MRB) and (4) the presence or absence of a biomolecule 
stabilizing agent (BioStab™ Biomolecule Storage Solution). These six conditions with 
the two buffers (see Figure 4.1) were examined systematically as described below. Each 
trial was conducted in triplicate, resulting in a total of 60 samples being measured. 
 
4.1.1 Reagents and materials 
All PhastSystem™ pre-cast gels, buffer strips, well combs, filter paper and ECL-Plus™ 
kits were purchased from Amersham Pharmacia Biotech (Baie d'Urfe, QC, Canada).   
Immuno-Blot® PVDF (polyvinylidene difluoride) membrane was purchased from Bio-
Rad Laboratories (Mississauga, ON, Canada). Polyclonal rabbit anti-human lysozyme 
was purchased from Cedarlane Laboratories (Hornby, ON, Canada) and goat anti-rabbit 
IgG-HRP was purchased from Sigma (St. Louis, MO, USA). Human lysozyme 
(neutrophil) was purchased from Calbiochem (La Jolla, CA, USA). A product developed 
specifically for stabilizing proteins and enzymes (BioStab™ Biomolecule Storage 
Solution – BioStab) was purchased from Sigma-Aldrich (St. Louis, MO, USA). All other 
reagents purchased were analytical grade and obtained from Sigma (St. Louis, MO, 
USA). 
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4.1.2 Protein deposit extraction from contact lenses 
Twelve lotrafilcon A (Focus® Night & Day™ CIBA Vision, Atlanta, GA) SH contact 
lenses were collected following 4 weeks of daily wear use, during which subjects had 
disinfected the lenses with AOSept (CIBA Vision). Lenses were aseptically collected 
using non-powdered surgical gloves and placed in individual glass vials containing 1.5 
ml extraction solution consisting of a 50:50 mix of 0.2% trifluoroacetic acid and 
acetonitrile (ACN/TFA). 74 The lenses were incubated in darkness at room temperature 
for 24 hours. Two 0.6 ml aliquots of ACN/TFA was transferred to sterile eppendorf tubes 
and lyophilized to dryness in a Savant Speed Vac (Halbrook, NY, USA). Dried protein 
pellets were stored at –70oC prior to reconstitution. 
 
4.1.2.1 Sample processing following extraction 
Figure 4.1 describes the sample processing following resuspension of the lyophilized 
sample extracts. Four 600 µl aliquots (2 X 600 µl from the right eye lens and 2 X 600 µl 
from the left eye lens of the same subject) of lyophilized lens extracts were taken and 
three of them were resuspended in 20 µl of either a standard reconstitution buffer (RB - 
10mM Tris-HCl; 1mM EDTA, pH 12) or a modified reconstitution buffer (MRB - 10mM 
Tris-HCl; 1mM EDTA, 0.9% saline, pH 12). Three of these 20 µl aliquots were pooled to 
total 60 µl and this volume was added to the fourth 600 µl aliquot of lyophilized Focus® 







Figure 4.1 Schematic of lysozyme processing following its extraction from lotrafilcon A lens material, 
lyophilization and resuspension. 
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4.1.2.2 Addition of enzyme stabilizer 
0.5 µl of the initial stock was taken and checked for neutrality using pH paper (Hydrion 
Papers, Micro Essential Laboratory, Brooklyn, NY, USA). Once neutrality was 
confirmed, 4 µl of the sample was added to 10 polypropylene sample tubes (Axygen 
MAXYMmum Recovery ™, Axygen Scientific, INC, CA, USA). 2.5 µl of BioStab was 
added to five samples and the same quantity of MilliQ water was added to the remaining 
five samples, which acted as the control group. 
 
4.1.2.3 Addition of gel loading buffer  
Six of the 10 samples were diluted with gel loading buffer (GLB - 5% SDS; 100 mM 
Tris, pH 7.4; 30% Glycerol; 1 mM EDTA; 0.02% bromophenol blue). The remaining 
four samples were stored under various conditions without gel loading buffer. 
 
4.1.2.4 Storage 
One set of samples were run without storage (fresh) and further samples were stored for 
48 hours, under various conditions (Figure 4.1). 
 
4.1.2.5 Lysozyme standard range  
Human lysozyme standard curves were run on each Western blot so that four points 
falling within the linear range of detection were produced, to facilitate regression analysis 
of sample extracts. Standards were prepared fresh on the day of analysis from a 0.2 
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µg/µL working solution of purified human neutrophil lysozyme. Standards were diluted 
with dilution buffer and then mixed with gel loading buffer (5% SDS; 100 mM Tris, pH 
7.4; 30% Glycerol; 1 mM EDTA; 0.02% bromophenol blue). The optimal set of 
concentrations for lysozyme quantification was determined to be 20, 10, 5 and 2.5 ng/µL.  
 
4.1.2.6 Electrophoresis and immunoblotting  
Prepared sample extracts and standards were boiled for three minutes after which 1 µL of 
each was loaded directly onto 8 X 1µl combs. All samples were subjected to SDS-PAGE 
on 10-15% gradient gels with a 13 mm stacking zone and 32 mm gradient zone on an 
automated minigel system (Amersham Pharmacia Biotech PhastSystem™) using the 
manufacturer’s specified conditions.   
 
Once separated, proteins were analyzed via Western blotting. PVDF membranes, that had 
been previously activated by soaking in 100% methanol for 60 seconds followed by 
transfer buffer (20 mM Tris, 150 mM glycine; 10% (v/v) methanol) for 25 minutes, were 
placed on the separation section of the gels for transfer in the PhastSystem™ using 
manufacturer’s specified conditions. Once transfer was complete, PVDF membranes 
were blocked for 2 hours in 20% blocking buffer [Tris-buffered saline (TBS) (50 mM 
Tris; 100mM NaCl pH 7.4); 20% (w/v) skim milk powder; 0.05% (v/v) Tween®-20]. 
Following blocking, membranes were washed 3 times, each 10 minutes in duration in 50 
mL of TBS with 0.05% Tween-20 (TBS-Tw). The membranes were then incubated at 
room temperature in 5% blocking buffer containing 1:1000 polyclonal rabbit anti-human 
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lysozyme for 1 hour and placed overnight at 4°C. Post washing, blots were incubated in 
5% blocking buffer for 1 hour at room temperature with 1:10 000 goat anti-rabbit IgG-
HRP conjugated secondary antibody. Following 2 washes/10 minutes each with TBS-Tw 
and one wash of 10 minutes with TBS, bound antibody was visualized by enhanced 
chemiluminescence (ECL Plus®). Optical density data was gathered by surrounding each 
of the eight bands with a fixed dimension box and was quantified on a Storm840® 
Imaging System (Molecular Dynamics, Sunnyvale, CA, USA) (Figure 4.2) set at 800V, 




Figure 4.2 Molecular Dynamics Storm840® Imaging System 
 
4.1.2.7 Quantification of densitometric data 
Quantification of lysozyme concentration found in each lens extract was carried out by 
densitometric analysis. Optical density (OD) was measured from digitized images of the 
PVDF membranes using ImageQuant 5.1 software. The OD of the four points derived 
from the lysozyme standard curve was graphed versus the concentration loaded.  Linear 
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regression was performed and the equation of the line-of-best-fit was used to calculate 
the lysozyme concentration in the sample extracts. The OD obtained from the digitized 
images of the sample extracts was substituted into the equation: 
                                                         x = (y – b)/m 
where y is the OD of the sample extract, m is the slope of the line calculated by linear 
regression, b is the y intercept as calculated by linear regression, and x is the 
concentration of purified lysozyme. A single digitized image contained 8 bands, 4 bands 
representing purified lysozyme and 4 bands representing sample extracts. Lysozyme 
bands migrated to a position representing a molecular weight of 14 kDa on the gels.  All 
samples were analyzed on duplicate gels to account for loading errors. 
 
Comparison of lysozyme band intensity in stored versus fresh samples enabled 
calculation of percentage mass loss of lysozyme. 
 
4.1.2.8 Negative controls - Testing for BioStab cross-reactivity in Western 
blotting 
In order to test if the enzyme stabilizer itself had any possible cross-reactivity during the 
Western blotting procedure, BioStab in conjunction with buffer alone was subjected to 
SDS-PAGE and Western blotting to PVDF membranes using the PhastSystem™, as 
described above.  
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4.2 Extraction Efficiency Study 
4.2.1 Reagents and materials 
The lenses that were used in the study are described in Table 4.1.  
Table 4.1 Lens parameters used in extraction efficiency study 
Proprietary name 
 Focus® Night 









Water content (%) 24 36 47 58 
Oxygen 
Permeability (Dk) 
140 99 60 22 
Centre thickness 
(mm) -3.00D 
0.08 0.09 0.07 0.07 
Oxygen 
Transmissibility 
(Dk/t) at 35˚C 
175 110 86 31 
FDA group I III I IV 
USAN Lotrafilcon A Balafilcon A Galyfilcon A Etafilcon A 
Stiffness (g/mm2) 130 110 55 35 
Base Curve (mm) 8.4, 8.6 8.6 8.3, 8.7 8.4, 8.7 
Total Diameter 
(mm) 
13.8 14 14 14 
 
 
Chicken egg white lysozyme was purchased from Sigma-Aldrich (St. Louis, MO, USA). 
Sterile, 5ml non-pyrogenic, polypropylene round bottom tubes were purchased from 
 43
Falcon (Franklin Lanes, NJ, USA). All other reagents purchased were analytical grade 
and obtained from Sigma (St. Louis, MO, USA).  
 
4.2.2 Doping of lenses in artificial lysozyme solution 
Figure 4.3 describes this experiment in a graphical format.    
Prepare lysozyme solution at a  
concentration of 1.9mg/ml  
Add 125I labeled lysozyme  
Dope the lenses in 1 mL of 
lysozyme solution for 28 days 
 
Figure 4.3 Schematic of protocol adopted to determine the extraction efficiency of 0.2% TFA/ACN in 
extracting lysozyme from Group IV and SH lenses. 
Count lenses 
(Total DPM)
Place lenses in the extraction 
buffer for 24 hrs in darkness 
Remove extract & determine 
radioactive counts (Extract DPM)
Remove lens & determine 
radioactive counts (Lens DPM) 
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Artificial lysozyme solution was prepared at a concentration of 1.9 mg/ml using 
Phosphate Buffered Saline (PBS), pH 7.4. Lysozyme labeled with 125I was used as the 
isotopic tracer to quantify protein adsorption to new contact lenses. 125I labeled lysozyme 
was added to unlabeled solution such that the samples had a counting rate of 105 
disintegrations per minute/ml (DPM/ml).  
 
As soon as the lenses were opened from the blister pack, they were initially rinsed with 
Phosphate Buffered Saline (PBS), pH 7.4 to ensure that the packaging solution did not 
enter the artificial lysozyme solution. The lenses were then placed in 1ml of the labeled 
lysozyme solution and were allowed to incubate at a temperature of 37° C with constant 
rotation for 28 days. The labeled lysozyme solution was replaced with identical quantity 
and counting rate every seven days, to simulate the process of replenishment of the tears.    
 
Following 28 days of doping, the lenses were aseptically collected using forceps and 
were rinsed briefly in saline to remove unbound protein sticking on to the lenses. The 
lenses were then placed in sterile, 5ml (12 X 75 mm), non-pyrogenic, polypropylene 
round bottom tubes and were counted in the Beckman Gamma 5500 Counter (Figure 





Figure 4.4 Beckman Gamma Counter 
 
4.2.3 Extraction of proteins from contact lenses 
The lenses were then placed in individual glass vials containing 1.5 ml of an extraction 
solution of 50:50 mixture of 0.2% trifluoroacetic acid and acetonitrile. 74 The lenses were 
incubated in darkness at room temperature for 24 hours. Following this the lenses were 
carefully removed from the vials and were placed in sterile, 5ml (12 X 75 mm), non-
pyrogenic, polypropylene round bottom tubes and the lenses were counted in the Gamma 
Counter (Beckman Gamma 5500). This count gave the total quantity of labeled protein 
that was remaining on the lens following its extraction (Lens DPM). Apart from 
measuring the lens DPM, the extract was also counted which gave counts of the extracted 
protein (Extract DPM). The percentage of lysozyme extracted from the lens was 
calculated by the formula used by Prager and co-workers, 122 




4.3 Kinetics Study 
4.3.1 Reagents and materials 
Chicken egg white lysozyme was purchased from Sigma-Aldrich (St. Louis, MO, USA). 
The lenses that were used in the study included three types of SH lenses and two types of 
conventional hydrogel lenses. The SH lenses included  Focus® Night & Day™  (Ciba 
Vision, Atlanta, GA, USA), PureVision™  (Bausch & Lomb, Rochester, NY, USA) and 
Acuvue® Advance™ (Vistakon, Johnson & Johnson, Jacksonville, FL, USA) (Table 
2.2). The conventional hydrogel lens materials that were used in this study are described 
in Table 4.2. Sterile, 5ml non-pyrogenic, polypropylene round bottom tubes were 
purchased from Falcon (Franklin Lanes, NJ, USA). All other reagents purchased were 
analytical grade and obtained from Sigma (St. Louis, MO, USA).  
 
Table 4.2 Conventional hydrogel lens materials evaluated in the kinetics study 
 Acuvue ® Soflens 66 
Water Content 58 % 66 % 
Monomers HEMA/ MA HEMA/ NVP 
USAN Etafilcon A Alphafilcon A 
Manufacturer Vistakon Bausch & Lomb 
FDA category Group IV Group II 
ISO category Filcon 1b Filcon 4a 
Manufacture Moulded Moulded 
Back Optic Zone Radius 8.7 mm “Medium” 
Total Diameter 14 mm 14.2 mm 
Center thickness 0.07 mm 0.10 mm 




Figure 4.5 describes this experiment in a graphical format. 
 
Prepare lysozyme solution at a concentration of 1.9mg/ml  
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Figure 4.5 Schematic of protocol adopted to determine the kinetics 
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4.3.2 Doping of lenses in artificial lysozyme solution 
Artificial lysozyme solution was prepared at a concentration of 1.9 mg/ml using 
Phosphate Buffered Saline (PBS), pH 7.4. Lysozyme labeled with 125I was used as the 
isotopic tracer to quantify protein adsorption to new contact lenses. 125I labeled lysozyme 
was added to unlabeled solution such that the samples had a counting rate of 105 
disintegrations per minute/ml (DPM/ml).  
 
As soon as the lenses were opened from the blister pack, they were initially rinsed with 
Phosphate Buffered Saline (PBS), pH 7.4 to ensure that the packaging solution did not 
enter the artificial lysozyme solution. The lenses were then placed in 1ml of the labeled 
lysozyme solution and were allowed to incubate at a temperature of 37°C with constant 
rotation for different time periods (Figure 4.5). The labeled lysozyme solution was 
replaced with identical quantity and counting rate, once in seven days in order to simulate 
the process of replenishment of the tears.   
 
Following the specified days of doping (Figure 4.5), the lenses were aseptically collected 
using forceps and were rinsed briefly in saline to remove unbound protein sticking on to 
the lenses. The lenses were then placed in sterile, 5ml (12 X 75 mm), non-pyrogenic, 
polypropylene round bottom tubes and were counted in the Gamma Counter (Beckman 
Gamma 5500). The amount of protein adsorbed to the lenses was calculated by dividing 
the counts on the lenses by the specific activity of the protein. 48 
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4.3.3 Data Analysis 
All data are reported as mean ± SD. Analysis of Variance was used to determine 
statistically significant differences between deposition across various time points and 
differences between materials at any time point. Post hoc multiple comparison testing 







4.4 Influence of rewetting drops on protein and lysozyme deposition 
4.4.1 Collection of human worn contact lenses 
One type of contact lens [lotrafilcon A, (Focus® Night & Day™ (FND), CIBA Vision] 
was collected from a clinical study within the Center for Contact Lens Research at the 
University of Waterloo, following completion of specified wear and care regimens. The 
study was conducted as a 2-month prospective clinical trial, using a randomized cross-
over design. Participants wore a pair of FND lenses on a daily wear basis. Each 
participant was issued one care system (OPTI-FREE® EXPRESS®) which was used in 
accordance with the manufacturer’s specifications. All participants were assigned to use 
either CLENS-100® (Alcon) or an unpreserved saline drop MINIMS sodium chloride 
(Bausch and Lomb) four times a day. After the first wearing period of 28 days, the lenses 
were replaced with a new set and the second drop was used.  
 
Upon completion of the 28-day wearing period, lenses were collected aseptically (using 
non-powdered surgical gloves) and placed in individual, sealed glass vials. The right eye 
lens was placed in 1.5ml of 50:50 mix of 0.2% trifluoroacetic acid and acetonitrile (ACN/ 
TFA). All lenses collected in ACN/TFA were maintained in the dark at room temperature 
for 24 hours. 74  
 
4.4.2 Reagents and materials 
All PhastSystem™ pre-cast gels, buffer strips, well combs, filter paper and ECL-Plus™ 
kits were purchased from Amersham Pharmacia Biotech (Baie d'Urfe, QC, Canada).   
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Immuno-Blot® PVDF (polyvinylidene difluoride) membrane was purchased from Bio-
Rad Laboratories (Mississauga, ON, Canada). Polyclonal rabbit anti-human lysozyme 
was purchased from Cedarlane Laboratories (Hornby, ON, Canada) and goat anti-rabbit 
IgG-HRP was purchased from Sigma (St. Louis, MO, USA). Human lysozyme 
(neutrophil) was purchased from Calbiochem (La Jolla, CA, USA). Chicken egg 
lysozyme and lyophilized Micrococcus lysodeikticus cells were purchased from Sigma 
(St. Louis, MO, USA). All other reagents purchased were analytical grade and obtained 
from Sigma (St. Louis, MO, USA). 
 
4.4.3 Protein deposit extraction from contact lenses 
Lenses collected in ACN/TFA were incubated in the dark at room temperature for 24 
hours. Two 0.70 ml aliquots of ACN/TFA was transferred to sterile eppendorf tubes and 
lyophilized to dryness in a Savant Speed Vac (Halbrook, NY, USA). Dried protein pellets 
were stored at –70oC prior to reconstitution. 
 
4.4.4 Sample processing following extraction in ACN/TFA-based extraction 
buffer 
Preliminary results in our laboratory demonstrated that lysozyme deposits extracted from 
silicone hydrogel contact lens materials demonstrated a loss in total mass as a function of 
storage time when assessed by Western blotting. This loss represents a potential source of 
error when quantifying total lysozyme deposition.  
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Hence, prior to electrophoresis, lyophilized protein pellets were reconstituted in modified 
reconstitution buffer (10 mM Tris-HCl; 1 mM EDTA, with 0.9% saline) pH 12.0 and 
BioStab™ Biomolecule Storage Solution (Sigma Aldrich). Reconstituted samples were 
used for Western blot, lysozyme activity analysis and total protein.  
 
4.4.4.1 Lysozyme standard range  
Human lysozyme standard curves were run on each Western blot so that four points 
falling within the linear range of detection were produced, to facilitate regression analysis 
of sample extracts. Standards were prepared fresh on the day of analysis from a 0.2 
µg/µL working solution of purified human neutrophil lysozyme. Standards were diluted 
with dilution buffer and then mixed with gel loading buffer (5% SDS; 100 mM Tris, pH 
7.4; 30% Glycerol; 1 mM EDTA; 0.02% bromophenol blue). The optimal set of 
concentrations for lysozyme quantification was determined to be 0.01, 0.005, 0.0025, 
0.001 µg/µL.  
 
4.4.5 Electrophoresis and immunoblotting 
Once prepared, samples were subjected to SDS-PAGE followed by Western blotting to 
PVDF membranes using the PhastSystem™ (Amersham-Pharmacia Biotech) as 
described earlier (Section 4.1.2.6) and also in a previously published paper. 13 
 
Lysozyme was identified using a rabbit anti-human lysozyme polyclonal antibody 
(Calbiochem), followed by a peroxidase conjugated goat anti-rabbit secondary antibody 
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(Sigma-Aldrich). Individual standard curves of purified human neutrophil lysozyme 
(Calbiochem) were run on each gel to facilitate regression analysis. Immunoreactivity 
was visualized by incubating with ECL Plus chemiluminescent substrate (Amersham-
Pharmacia Biotech). Optical densities of the resulting bands were quantified from 
digitized images created with a Molecular® Dynamics Storm™ 840 Imager using 
ImageQuant™ 5.1. 
 
4.4.5.1 Negative control - extraction and western blot analysis of unworn lenses 
Three new, unworn FND lenses were extracted in ACN/TFA solution and were subjected 
to SDS-PAGE and Western blotting, as described above. 
 
4.4.6 Measurement of lysozyme activity 
The extracts were assayed for lysozyme activity using a fresh suspension of Micrococcus 
lysodeikticus for each sample. Two milligrams of desiccated micrococcyl cells were 
weighed out and suspended in a volume of 50 mM sodium phosphate buffer (pH 6.3) 
such that an initial optical density (OD) of 0.9-1.0 was achieved at 450 nm (Multiskan 
Spectrum ELISA Plate Reader, fitted with a micro-cuvette, ThermoLabsystems). 1 ml of 
buffered micrococcyl solution was used for each sample tested. Each 1 ml volume was 
placed in a 1.5 ml cuvette and incubated in the cuvette housing at 30o C. All samples were 
compared to the results of 0.1 µg human neutrophil lysozyme standard added to a 1 ml 
volume from the same batch of buffered micrococcyl solution. The initial optical density 
at 450 nm (OD450), was taken for all samples (time=0) as well as at 30 second intervals 
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for a length of five minutes after the addition of the appropriate volume of sample (added 
in a volume of no more than 10 µl). The deviation in OD450 between each time point 
from time zero was calculated and plotted.  
 
Linear regression analysis was then applied to the curve. Experiments with R2 values 
higher than 0.98 were only used. The equation of the regression line was calculated to 
give the slope. Specific activity (SA) for the standard and each sample tested was then 
determined using the equation:  
SA = slope x 1000/mg of lysozyme used 
 
As both the standard and sample specific activities were known (and were determined 
from the same micrococcyl stock solution), one could directly compare the effects of the 
same quantity of lysozyme on the micrococcyl solution. Finally, to determine the amount 
of lysozyme from the lens extract still in native form, the following formula was 
employed:  
Native lysozyme = total lysozyme (sample SA / standard SA) 
where total lysozyme was pre-determined via Western blot analysis as described above.  
 
The denatured lysozyme component was derived by:  
Denatured lysozyme = total lysozyme – native lysozyme 
 
The final calculation was the percent of denatured lysozyme:  
% denatured total lysozyme = (denatured lysozyme / total lysozyme) x100 
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4.4.7 Measurement of total protein deposition 
Amido Black Dot Blot Protein Assay was used to determine the total protein deposited on 
the lenses. In this method, Nitrocellulose membrane (Bio-Rad Laboratories, CA, USA) 
was pre-treated with 15% (v/v) phosphoric acid and 10% (v/v) methanol for one minute. 
This pre-treated membrane was blotted between two sheets of filter paper and air-dried at 
room temperature. This membrane was placed in water briefly and was positioned into 
the Bio-Dot ® Microfiltration Apparatus (Bio-Rad Laboratories). A fresh set of protein 
standards was prepared by diluting 2.0mg/ml BSA stock standard in Phosphate-buffered 
saline (PBS) at pH 7.2. Protein solutions (concentrations ranging between 0.5 and 16 
µg/ml) were applied to membrane in 50 µl volumes. Following the application of stock 
and the sample solutions, all the wells were rinsed with 100µl of PBS. After rinsing, the 
membrane was air-dried and was immersed in 1.5% glutaraldehyde for 5 minutes. Then 
the membrane was washed twice with 1N NaOH to remove glutaraldehyde and then with 
0.05% (v/v) HCl solution to neutralise NaOH. The membrane was then immersed in 
Amido Black Stain [0.1% (w/v) amido black, 5% (v/v) methanol, 10% (v/v) glacial acetic 
acid]. The membrane was then destained with large volumes of 40% (v/v) methanol, 10% 
(v/v) glacial acetic acid and was dried at room temperature. Stained protein dot-blots 
were imaged on the Syngene® with GeneSnap™ using white light and were quantified 
using Gene Tools™.  
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4.4.8 Data Analysis 
All data are reported as mean ± SD. All data were tested for normality using 
Kolmogorov-Smirnov test. If the data proved to be parametric, then student t-test was 
used to determine statistically significant differences between the two care regimens. If 
the data proved to be non-parametric in nature, then a non-parametric Wilcoxon signed 
rank-sum test was used. In all cases, significance level was taken as p < 0.05. 
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5 Results 
5.1 Stabilization study 
Table 5.1 shows the percentage of lysozyme loss when the lyophilized sample extracts 
were resuspended in the “standard” reconstitution buffer, stored with and without the 
addition of BioStab, gel loading buffer and under the two storage temperatures (-20º C 
and -70º C).  The addition of BioStab significantly reduced the amount of lysozyme mass 
loss. 
 
Table 5.1 Percentage loss of lysozyme after 48 hours of storage when the samples were resusupended 
in the Standard Reconstitution Buffer. 
-20°C -70°C 
 
No Biostab With Biostab 
p No Biostab With Biostab p 
With GLB 32.9% ± 0.6 14.3% ± 2.5 < 0.001 31.3% ± 1.1 13.1% ± 1.9 < 0.001 
Without 
GLB 33.5% ± 0.7 15.1% ± 1.5 < 0.001 31.7% ± 1.3 13.1% ± 1.3 < 0.001 
 
 
Table 5.2 shows the percentage of lysozyme loss when the lyophilized sample extracts 
were resuspended in the “modified” reconstitution buffer, stored with and without the 
addition of BioStab, gel loading buffer and under the two storage conditions (-20º C and  




Table 5.2 Percentage loss of lysozyme after 48 hours of storage when the samples were resusupended 
in the Modified Reconstitution Buffer. 
-20°C -70°C 
 
No Biostab With Biostab 
p No Biostab With Biostab p 
With GLB 19.2%  ± 4.5 0.9% ± 0.8 < 0.001 17.1% ± 2.8 0.6% ± 0.8 < 0.001 
Without 
GLB 19.5%  ± 4.3 1.4% ± 1.3 < 0.001 18.2% ± 1.9 1.1% ± 1.4 < 0.001 
 
 
A four way analysis of variance was performed for all the data. The results indicated that 
buffer composition (p<0.001), storage temperature (p=0.04) and addition of BioStab 
(p<0.001) were all important in controlling loss of mass of lysozyme over time. 
However, no significant difference was found when the samples were stored with and 
without the addition of gel loading buffer (p=0.373). 
 
No signal was seen on negative control Western blots run with BioStab, indicating that 
the enzyme stabilizer itself is not cross reactive with the Western blotting procedure used 




5.2 Extraction efficiency study 
The extraction efficiency for different lens types using the 0.2% TFA/ACN extraction 
buffer is detailed in Figure 5.1. 
 
























Figure 5.1 Percentage of lysozyme extracted by 0.2% TFA/ACN from different lens types 
 
Analysis of Variance was performed for all the data. The results indicated that there were 
significant differences between etafilcon and lotrafilcon A (p<0.001) and etafilcon and 
balafilcon lens materials (p<0.001). Post hoc analysis by Tukey test showed that there 
was no significant difference between etafilcon and galyfilcon lens materials (p=NS). 
 60
5.3 Kinetics Study 
Figures 5.2 and 5.3 show the kinetics of lysozyme deposition on alphafilcon and etaficon 
lens materials, while Figure 5.4 shows the kinetics of lysozyme deposition on the three 























































































































Group IV lens material 
 
Figure 5.3 Lysozyme deposition curve for Etafilcon A (Group IV) lens material 
 
Etafilcon lens material deposited significantly more lysozyme than all other lens 
materials (p<0.001). In the Group IV lens material, the amount of lysozyme increased 
significantly between days 1 and 7 (p<0.001) and then reached a plateau, with no further 







































Silicone Hydrogel lens materials 












Figure 5.4 Lysozyme deposit curve on FND, PV and AA (SH) lens materials  
 
With the Group II and SH lens materials there was a significant increase in lysozyme 
deposition across all time points (p<0.001). At 7 days, lotrafilcon A lenses deposited 
1.8±0.4 µg of lysozyme per lens while balafilcon and galyfilcon lenses deposited 5.9±2 
and 3.6±1 µg of lysozyme respectively. After 28 days of doping, lotrafilcon A lenses 
deposited 4.2±1 µg of lysozyme per lens while balafilcon and galyfilcon lenses deposited 
19.4±3 and 16.8±4 µg of lysozyme respectively.  
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There was a significant difference in lysozyme deposition between the conventional lens 
materials and all the three SH lens materials across all time periods (p<0.001). Between 
SH lens materials, Bonferroni post-hoc analysis showed that there were no significant 
differences between lotrafilcon A, balafilcon and galyfilcon lens materials until 3 days 
(p>0.05). There were significant differences in lysozyme deposition between balafilcon 
versus galyfilcon (p<0.05), lotrafilcon A versus balafilcon lenses (p<0.001) and 
lotrafilcon A versus galyfilcon lenses (p<0.001) across all time periods after 5 days.  
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5.4 Influence of rewetting drops on protein and lysozyme deposition 
5.4.1 Western blot quantification of lysozyme deposition 
Lysozyme standard curves gave a range of R2 values between 0.97 and 0.99, as 
demonstrated in Figure 5.5. Table 5.3 details the lysozyme deposition on FND lenses 
when subjects used an unpreserved saline drop versus a rewetting drop (CLENS-100®). 
The results demonstrate that lysozyme deposition was greater when subjects used 
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western blot on FND lens extracts. Lanes 1-4: Lysozyme standard curve (Lane 
0.005; Lane 3: 0.0025; Lane 4: 0.001 µg/µl). Lanes 5-6: Protein extracts from 
n subjects used MINIMS sodium chloride. Lanes 7-8: Protein extracts from 
 subjects used CLENS 100. (b) A typical regression curve created by graphing 
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sulting band immunoreactivity. Lysozyme concentration of lens extracts was 
rapolation from this curve.   
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Table 5.3 Summary of lysozyme deposition data (N = 25). 
MINIMS NaCl CLENS-100® 
Lysozyme 
(µg/lens) Range (µg/lens) 
Lysozyme 





1.14 ± 0.7 0.53 to 3.13 0.73 ± 0.5 0.34 to 2.14 < 0.001 
 
 
5.4.2 Assessment of lysozyme activity 
A summary of the lysozyme activity results is presented in Table 5.4. The percentage of 
denatured lysozyme was reduced when subjects used CLENS-100® drops when 
compared with the control drops (p=0.002). 
 
Table 5.4 Summary of lysozyme activity data (N = 25) 
MINIMS NaCl CLENS-100® 
% Denaturation 
per lens Range (%) 
% Denaturation 





85 ± 7 71 to 98  76 ± 10 64 to 97  0.002 
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5.4.3 Total protein 
Table 5.5 details the total protein deposition found on FND lenses. Total protein 
deposited on FND lenses was significantly greater when MINIMS Sodium Chloride was 
used than when CLENS-100® was used (p<0.001).  
 
Table 5.5 Summary of total protein deposition data (N = 25) 
MINIMS NaCl CLENS-100® 
Total protein 
(µg/lens) Range (µg/lens) 
Total protein 









6 Discussion and conclusions 
There are over 60 proteins that have been detected in the tear film 134 and among these 
lysozyme has attracted the greatest attention. 2, 7, 38, 54, 55 Several studies have reported that 
lysozyme is the predominant tear film protein deposited on hydrogel lenses 7, 42, 44-46, 71, 72 
and also that it plays an important role  in ocular immunology. 30-33, 135, 136  Hence I chose 
to focus on the analysis of lysozyme deposited on SH lenses and also on its extraction 
and deposition as a function of time on SH lenses and compare it with what is seen on 
conventional hydrogel lens materials.  
 
A method has been optimized in our laboratories to quantify the minute quantities of 
lysozyme deposited on SH lens materials. 13 One of the objectives of this thesis was to 
enhance this existing technique, such that the deposits extracted from SH contact lenses 
could be accurately and sensitively analyzed. Thus, the first project of this thesis involved 
the development of a method whereby lysozyme mass extracted from SH lens materials 
would be preserved over time and would be compatible with the optimized Western 
blotting procedure. This methodological development was incorporated into a clinical 
study wherein the difference in the degree of total protein, the difference in lysozyme 
deposition and activity recovered from lotrafilcon A SH lens material when subjects used 




The remaining studies were in vitro experiments wherein the lenses were doped in 
artificial lysozyme solution containing 125I-labeled lysozyme. These experiments were 
performed to gain insight into: 
 
1. the efficiency of extraction of the 50:50 mix of 0.2% trifluoroacetic acid and 
acetonitrile (ACN/TFA) (as this extraction reagent has been fully validated for 
traditional hydrogel lenses, but not for SH lenses) 
2. the kinetics of lysozyme deposition on SH lenses and compare it with Group IV 









6.1 Stabilization Study 
Preliminary work in our laboratories has shown that there is a substantial loss in 
lysozyme mass following extraction from SH lenses and subsequent processing 
(lyophilization, resuspension and storage). This is particularly true for lotrafilcon-based 
materials. Such loss in lysozyme mass has been previously reported by other groups 
looking at tears 94 and saliva, 95 but in these cases the concentration of lysozyme was 
significantly higher than that typically found on lotrafilcon-based hydrogel lenses, which 
typically deposit <5µg of lysozyme per lens. 12-14 An alternative reason for this loss in 
lysozyme mass is that lysozyme may undergo dimerization 99 or aggregation, 137 resulting 
in failure to be recognized by the antibody used in our Western blotting assay. However, 
preliminary work in our lab suggests that dimerized lysozyme would be detected with the 
polyclonal antibody used in this assay. Thus, my goal was to devise a protocol to reduce 
the degree of lysozyme loss, as this would serve as a significant tool for many research 
areas in which the examination of small amounts of lysozyme, in either solution or on the 
surface of biomaterials, is important. 
 
Lysozyme is a globular protein which is relatively stable when compared to most other 
proteins found in tears. However, in the quantitation of lysozyme deposited on a contact 
lens, (which, depending on the quantification method, may require a significant degree of 
initial processing such as extraction, lyophilization, resuspension and storage), it is 
possible that the conformational state of any protein, including lysozyme, could be 
significantly altered. Altered conformation has significant implications if the quantitative 
technique being employed uses an antibody to recognize the protein of interest (for 
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example Western blotting or ELISA) and may be more critical than if the protein is being 
quantified by a method that does not involve antibody recognition (for example, High 
Performance Liquid Chromatography).  
 
The stability of proteins in solution has been a major concern for biotechnologists and the 
pharmaceutical industry. Several studies have been conducted and it has been recognized 
that long term stability of proteins can be improved by adding substances such as sugars 
(eg Dextran, 138-140 Trehalose, 141-143 Sucrose 143, 144), salts 145-149 and polyols such as 
Sorbitol. 150, 151 The current understanding of protein stabilization has been achieved by 
thermodynamic measurements of interactions and micro-environmental changes 
occurring upon addition of a stabilizing compound and also through Nuclear Magnetic 
Resonance Spectroscopy (NMR), Differential Scanning Calorimetry (DSC) and Circular 
Dichroism (CD). It is believed that the stabilizing phenomenon is a complex one and no 
single mechanism is responsible for stabilization.  
 
This project set out to develop a protocol that would reduce the loss in lysozyme mass 
over time from an elute from a SH contact lens. The two potential protein stabilizers that 
were used in this study were 0.9% saline and a proprietary product developed for protein 
stabilization (BioStab™ Biomolecule Storage Solution). The presence of buffer or salt 
solution is believed to maintain the native conformational state of lysozyme. 148 The 
stabilizing effects of salts have been attributed mainly to their ability to mask the protein 
of interest from the surrounding solvents. The exclusion of harsh solvents from the 
protein surface leads to ‘preferential hydration’ of the protein or ‘preferential exclusion’ 
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of the additive from the protein surface, limiting their denaturing effect. BioStab™ 
Biomolecule Storage Solution is a solution which is free of DNAses, RNAses and 
proteases. This product is an aqueous solution which contains a non-ionic detergent and 
is non toxic. The producers and distributors of the product claim that this product 
increases storability of biomolecules such as enzymes, antibodies and DNA. Despite 
repeated attempts to obtain the exact chemical composition of the product, I was unable 
to obtain any further information and thus am unable to ascertain what components were 
exactly responsible for imparting such a protective effect during our analysis. However, 
examination of Tables 5.1 and 5.2 clearly demonstrate that this product has a marked 
influence in controlling the loss of lysozyme mass over storage time, with no apparent 
impact on its ability to be recognized by a suitable antibody.  
 
The samples were tested by storing them with and without the addition of gel loading 
buffer in order to determine whether any of the components in the gel loading buffer was 
responsible for altering the structure of lysozyme. One of the major components in the 
gel loading buffer is glycerol (at a concentration of 30%). Glycerol itself has a potential 
stabilizing effect on protein molecules, 151, 152 however, we did not find any significant 




A procedure has been optimized using a modified reconstitution buffer, BioStab™ 
Biomolecule Storage Solution and storage at -70°C in which the percentage loss of 
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lysozyme following extraction from lotrafilcon A contact lenses has been reduced from 
approximately 33% to less than 1%. This revised protocol will be of significant value for 
researchers interested in studying the deposition of proteins onto substrates in both ocular    
and non-ocular research areas.    
 
This study was conducted on deposited lysozyme recovered from only one type of SH 
contact lens material. Further work must be undertaken to examine the impact of this 







6.2 Extraction Efficiency Study 
This study specifically investigated the efficacy of the removal of lysozyme from 
etafilcon and three types of SH lens materials (lotrafilcon A, balafilcon and galyfilcon) 
using an in vitro deposition model. This technique was sensitive enough to investigate the 
extraction efficiency from SH lens materials, which deposit very low quantities of 
lysozyme. Extraction of proteins from hydrogel lenses using 0.2% TFA/ ACN is a 
commonly reported technique 12, 74, 104, 122, 153 and this buffer has been used previously for 
extraction of deposits from SH materials. 12, 13, 27 However, only one study has discussed 
the efficacy of removing lysozyme by the acid-based extraction technique and has 
compared that with SDS-based methods for SH lens materials. 13  
 
The results from this study demonstrate that the method developed by Keith and 
colleagues based upon TFA and ACN is 100% efficient in removing lysozyme from 
artificially spoiled etafilcon lens materials, which is consistent with the data from Keith 
and colleagues. 74 The mechanism for protein removal by this solution is thought to be 
due in part to an ion exchange interaction between the solution, protein and lens, along 
with strong solvation properties of the acetonitrile-trifluoroacetic acid mixture. 74 As the 
solution is acidic, it readily provides protons to interact with negative sites in the lenses. 
This can occur as an ionic interaction at an open negative site or as an exchange at an 
existing ionic bond between protein and lens. 154  In addition, the solution has strong 
solvation properties for proteins, in that it has ionic, aqueous and organic properties. 
Thus, the combination of these two properties provides a means of removing protein from 
lenses and readily solubilizing and maintaining it in solution. 154 However, the efficacy of 
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this method in extracting lysozyme from SH lens materials is lower. Although the current 
method could extract 91.4 ± 1.4 % of the lysozyme deposited on artificially spoiled 
galyfilcon lenses, it could extract only 66.3 ± 5.2 % and 56.7 ± 3.8 % from lotrafilcon A 
and balafilcon lenses respectively.  
 
The possible reason for this reduced extraction efficiency from these two lens types could 
be due to the surface modification process that is involved with these lens materials. The 
surfaces of the lotrafilcon lenses are permanently modified in a gas plasma reactive 
chamber 23, 25 while the balafilcon lenses are surface treated in a gas plasma reactive 
chamber, which transforms the silicone components on the surface of the lenses into 
hydrophilic silicate compounds. 23, 26 No surface treatment is required for etafilcon and 
galyfilcon lenses. Hence this surface modification process in lotrafilcon A and balafilcon 
lens types could interfere with the buffer’s ability to break the bonds between deposited 
lysozyme and the lens surface resulting in decreased extraction from these two lens 
materials. 
  
It is a well established fact that lysozyme deposition is affected by the water content and 
the ionicity of lens materials. 2, 3, 5, 7, 37, 47, 79, 120, 155 However, it is not known if these 
factors affect lysozyme removal or if the extraction buffers are strong enough to 
overcome these effects. The ability of the components of an extraction buffer to break 
chemical bonds and encapsulate proteins for removal from the contact lens surface is 
determined by the extraction efficiency. Each type of protein deposited on a material may 
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have a different set of bonds and steric constraints, allowing it to remain on the surface. 
The extraction buffer should have the ability to break these interactions.  
 
It is clear that SH lenses will still deposit significantly less lysozyme compared to 
traditional hydrogels. To overcome this issue of inefficiency, a new buffer has to be 
developed which has the capability to remove 100% of lysozyme from SH lenses, which 
will have minimal effect on lysozyme conformation and will be compatible with current 
and future methodologies used to quantify lysozyme concentration and conformation. 
Hence, the development of an efficient method to extract lysozyme from SH lens 
materials will be a valuable step in the investigation of the interaction of these contact 
lens materials with the human tear film. 
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6.3 Kinetics Study 
Although radiochemical analysis offers great sensitivity for quantitation of small amounts 
of material, it has been used infrequently to measure deposition of tear components on 
contact lenses. Lysozyme was selected for these studies because it is a recognized 
prominent lens soilant and a significantly greater quantity of lysozyme binds to ionic, 
high-water-content (Group IV) lenses than to other types of lenses and is therefore often 
used as the prototypical marker for protein accumulation. 7, 74, 98 It is widely recognized 
that the adsorption of proteins at the contact lens surface is complex and depends upon a 
number of factors. Notable among these are material water content and surface charge. 3, 
7, 37, 42, 46, 47, 79, 96, 120
  This is the first study to look at the kinetics of lysozyme deposition 
on SH lens materials and compare it with Group IV and Group II lens materials. 
 
Examination of Graph 5.3 shows that etafilcon A lenses (Group IV) attracted substantial 
quantities of protein, which was significantly greater than that measured on the 
alphafilcon A (Group II) and SH lenses (p < 0.001). This finding is in accordance with all 
other previous studies examining protein and lysozyme deposition on different lens 
groups. 2, 3, 5, 7, 47, 79, 156 This is because methacrylic acid imparts a negative charge to the 
material and thus thermodynamically favors the deposition of lysozyme which is a 
positively charged species. Lysozyme accumulated rapidly on Group IV lenses (1 hr, 
98±8 µg/lens), reached a maximum on the 7th day (1386±21 µg/lens) and then reached a 
plateau, with no further increase occurring (p=NS). 
 
 77
Previously published in vitro studies investigating the kinetics of protein deposition on 
conventional hydrogel contact lens materials, most of which use lysozyme 38, 54, 104, 112, 113, 
122 or albumin-containing 48, 109, 110 artificial tear solutions, indicate that the initial 
accumulation of protein on hydrogel materials is rapid, occurring within minutes of 
exposure to a protein-containing solution. 38, 48, 109, 110, 112, 122 The kinetics of lysozyme 
adsorption on Group IV lenses broadly follows a three-phase process, with initial 
adsorption, followed by a rapid increase in which saturation occurs rapidly, and finally a 
plateau. 38, 54, 110, 111, 113 They also indicate that the ionic binding capacity, water content, 
and chemical composition of the underlying polymer has a significant impact on the type 
and extent of protein deposited. 38, 48, 110, 113    
 
In the group II and SH lens materials, lysozyme deposited was significantly less than that 
seen with the group IV lenses. The amount of lysozyme deposition increased gradually 
across all time points and no plateau was achieved (p<0.05) (Figures 5.2 and 5.4). Hence, 
the kinetics of lysozyme deposition pattern in SH lenses were similar to that of Group II 
lenses in that no plateauing was seen even after 28 days of doping. At 7 days, FND lenses 
deposited 1.8±0.4 µg of lysozyme per lens while PV and AA lenses deposited 5.9±2 and 
3.6±1 µg of lysozyme respectively. After 28 days of doping, FND lenses deposited 4.2±1 
µg of lysozyme per lens while PV and AA lenses deposited 19.4±3 and 16.8±4 µg of 
lysozyme respectively. Results from this study also clearly demonstrates that SH contact 
lens materials deposit significantly less lysozyme compared to traditional hydrogel 
materials. Obvious potential factors relate to the differences in surface treatment and bulk 
composition between the currently available SH lenses. 
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SH contact lens materials represent a new family of biomaterials that have properties 
unlike any other previously developed for contact lens use. In addition to differences in 
surface modification, there are fundamental differences in the bulk chemistry of the 
polymers. The surfaces of the three (of the four commercially available SH lenses) are 
surface treated in an attempt to improve the wettability of the materials and to reduce the 
degree of deposition. 25 Galyfilcon lenses incorporate a long chain, high molecular weight 
molecule called Hydraclear™, which maintains flexibility and moisture. This wetting 
agent is present throughout the lenses and hence no surface treatment is required for these 
lenses. 27 Because of their unique surface and bulk properties, these newly developed SH 
lens materials are highly resistant to protein deposition. It is difficult to predict and 
explain the process of deposition in these newly developed SH lens materials.  
 
6.3.1 Conclusions 
To-date this is the first study to look at the kinetics of lysozyme deposition on SH lens 
materials. Radiochemical analysis is a sensitive and effective technique to determine the 
small quantities of lysozyme deposited on SH lenses. The kinetics of contact lens 
deposition depends on the chemical structure of lens material under consideration. 
Lysozyme deposition occurs rapidly with Gp IV materials before reaching a maximum, 
while SH and Gp II materials progressively accumulate lysozyme, with no plateau 
occurring. 
 
The kinetics of material build-up on lenses has ramifications for both lens replacement 
frequency and the regularity of care and maintenance. Elucidating the apparent 
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differences between studies that do and do not show plateauing may be an important 
feature in relating deposition to symptomatology. Examination of methodology, 
differences in lens materials, denaturation of protein, and changes of the inflammatory 
state of the eye over longer wearing periods may explain these findings. All results 
analyzing the role of deposition in successful contact lens wear should be viewed against 
the background of lens age.  
 
6.3.2 Future directions 
One of the biggest drawbacks of this study was that the lenses were doped in a solution 
containing only one type of protein, namely lysozyme. An important factor to consider in 
the process of deposition relates to whether other substances from the tear film (for 
example mucins or other proteins) concurrently deposit onto the material surface at 
different rates. Hence it is necessary to look at the kinetics of deposition using a complex 
artificial tear solution and to look at the protein-protein, protein-lipid and protein-mucin 
interactions. It is clear that SH lenses only deposit small amounts of lysozyme and 
previously published studies suggest that much of this lysozyme is denatured. 12, 13 Hence 
it would be interesting to look at the activity of lysozyme recovered at various time 
points. In addition to looking at kinetics of deposition, the kinetics of denaturation and 
how they relate to wearing period, the influence of various care regimens, and the degree 
to which other tear proteins denature also require investigation.  
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6.3.3 Comparison of in vitro experiments to in vivo studies 
Soft lenses are not always readily obtained for analysis from clinical sources. A number 
of studies have found artificial tear solutions an attractive option in determining the 
binding affinity of different components and the mechanisms involved in such binding. 
110, 121-129 The principal advantages are that many experimental variables are eliminated, 
quantitation can be enhanced by labeling the species fluorometrically or radiometrically, 
and simple hypotheses can be tested without having to engage in a resource consuming 
clinical trial.  
 
However, the real world provides a complex array of variables that cannot be excluded 
from having an influence in clinical lens spoilage. Such effects include the cycle of 
evaporative drying and wetting created by the blinking action, the mechanical aspect of 
shear forces during blinking, differences in tear film protein and lipid composition, 
structure of the tear film, replenishment rate and volume of tears, wearing times, wearing 
conditions (for example outdoor or air-conditioned environments and proximity to 
chemical agents), ultraviolet light exposure, wearing mode (extended wear versus daily 
wear), interactions between the items under test and other tear film components, and the 
influence of external contaminants. Moreover, some evidence suggests that deposit 
formation is caused in part by the thinning and drying of the tear film, resulting in the 
lipid layer directly collapsing onto the lens surface and partitioning into the dry lens 
surface. 157, 158 Hence, in vitro results may not be directly transferable to the in vivo state. 
However, these in vitro studies will provide valuable guidance for further in vivo studies. 
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6.4 Influence of rewetting drops on protein and lysozyme deposition 
A number of studies have investigated the effect of surfactants on hydrogel lens 
materials. 36, 105, 128, 159-166 To-date, this study is the first of its type which has examined 
the potential use of surfactant-containing rewetting drops with silicone hydrogel lenses. It 
is a well established fact that the major problem associated with silicone hydrogel lens 
wear is dryness and associated discomfort that develops over the course of the day. This 
study investigated the impact of treating SH lenses during their wearing period with a 
novel rewetting agent that has been specifically developed to reduce in-eye deposition on 
polyHEMA-based materials. 
  
The results from this study demonstrate that total protein deposition (Table 5.5), 
lysozyme deposition (Table 5.3) and lysozyme denaturation (Table 5.4) were all 
significantly reduced when subjects used CLENS-100® compared with the control saline 
drop. The components of CLENS-100® include a surfactant designed to remove protein, 
lipids and debris, named Polyethylene glycol -11 lauryl ether carboxylic acid (also called 
RLM-100, a patented product); and the other important component is a substance that 
guards lenses against future protein build-up, named poloxamine. One other component 
is Tetronic® 1304, which helps the lenses to retain moisture and also helps to shield the 
lens from future protein build-up. Hence the total protein deposition and lysozyme 
deposition recovered from the lenses were significantly lower (p<0.001) when the 
subjects used CLENS-100® instead of MINIMS sodium chloride.  
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Generally, surfactants are used by the manufacturers, and include in them high molecular 
weight substances such as poloxamine (or poloxamer) or a lower molecular weight 
substance named tyloxapol. 167 Theoretically, it has been suggested that surfactants would 
alter the interfacial chemistry at the molecular layer between the contaminant and lens. 
Following this, polar micelles would form and they would entrap the debris and enable 
them to be rinsed away. Clinically, solutions containing a surfactant have been reported 




Table 5.4 indicates that the amount of denatured lysozyme recovered from lotrafilcon A 
lenses was 76 ± 10% when the subjects used CLENS-100® which was significantly 
lower than when subjects used MINIMS sodium chloride (85 ± 7%). The degree to which 
protein denaturation occurs is mediated by a number of factors, including contact time 
with the substrate, chemical composition of the substrate, protein type, surrounding pH, 
and temperature. Proteins are most likely to denature when exposed to strongly 
hydrophobic surfaces. 38, 170-174 The use of a surfactant containing rewetting drop could 
have probably increased the hydrophilicity of the contact lens surface. This would lead to 
lysozyme deposited on lenses getting exposed to a lesser hydrophobic surface resulting in 
lower denaturation.  
  
Given the known link between protein deposition and immunological changes induced 
during lens wear, it is possible that reduced protein deposition and a reduction in 
denatured lysozyme could result in improved vision, reduced mucous discharge and 
palpebral lid changes. The results from this study were remarkably consistent and 
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strongly suggest that practitioners should consider prescribing surfactant-containing 
rewetting drops to patients who use lenses on a continuous wear basis. Silicone hydrogel 
chemistry is unique - new conditioning/ rewetting products will likely be needed as the 
popularity of this material grows. The results obtained would provide valuable 
information about the potential for surface modification of these polymers in-situ. 
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6.5 Summary  
1. A procedure has been optimized using a modified reconstitution buffer, 
BioStab™ Biomolecule Storage Solution and storage at -70°C in which the 
percentage loss of lysozyme following extraction from lotrafilcon A contact 
lenses has been reduced from approximately 33% to less than 1%. This revised 
protocol will be of significant value for researchers interested in studying the 
deposition of proteins onto substrates in both ocular and non-ocular research 
areas.  
2. The results from the extraction efficiency study showed that 0.2% trifluoroacetic 
acid/ acetonitrile was not 100% efficient in extracting lysozyme deposits from 
lotrafilcon A and balafilcon lens materials. However, it was efficient in extracting 
lysozyme deposited on etafilcon and galyfilcon lens materials. 
3. The kinetics of lysozyme deposition on SH lenses was determined using an in 
vitro model. These results demonstrate that the kinetics of lysozyme deposition is 
material dependent and reiterates that SH lenses deposit very low amounts of 
lysozyme compared to conventional lenses.  
4. The impact of treating SH lenses during their wearing period with a novel 
rewetting agent that has been specifically developed to reduce in-eye deposition 
was also investigated. The results from this study demonstrate that total protein 
deposition, lysozyme deposition and lysozyme denaturation were all reduced 
when subjects used a surfactant containing rewetting drop instead of a control 
saline drop.   
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